Welcome to our dedicated page for TRxADE HEALTH news (Ticker: MEDS), a resource for investors and traders seeking the latest updates and insights on TRxADE HEALTH stock.
TRxADE Health, Inc. (MEDS) operates a pioneering web-based platform transforming pharmaceutical procurement through competitive supplier markets and data analytics. This news hub provides essential updates for stakeholders tracking the company’s impact on healthcare supply chain efficiency.
Key updates include strategic partnerships, platform enhancements, and financial performance. Access verified press releases about MEDS’ e-commerce innovations, regulatory milestones, and market expansion efforts.
Discover announcements about supplier network growth, analytics feature upgrades, and compliance achievements. Our curated news collection helps investors assess MEDS’ role in modernizing pharmaceutical purchasing through technology-driven solutions.
Bookmark this page for real-time updates on TRxADE Health’s initiatives in secure pharmaceutical transactions and data-driven procurement strategies. Stay informed about developments shaping the future of healthcare supply chain management.
Trxade Group, Inc. (MEDS) has announced the postponement of its virtual roadshow, originally set for February 3, 2021. The new date will be communicated through a future press release, which will include webcast links and dial-in information. CEO Suren Ajjarapu expressed gratitude to shareholders for their patience while emphasizing the company's focus on achieving short-term business objectives. Trxade Group operates as a comprehensive drug procurement and healthcare platform across the U.S. with a mission to enhance price transparency in the pharmaceutical market.
Trxade Group, Inc. (NASDAQ:MEDS) will hold a virtual roadshow on February 3, 2021, at 11:00 a.m. Eastern Time. CEO Suren Ajjarapu will present the company’s business model and growth initiatives, followed by a Q&A session. Interested participants can join via the provided webcast link or dial-in numbers. The U.S. Dial-in is 1-877-425-9470, and the International Dial-in is 1-201-389-0878. A playback will be accessible until February 17, 2021, with additional information available on the Trxade Group website.
Trxade Group (NASDAQ: MEDS) announced a strategic partnership between its telehealth subsidiary, Bonum Health, and KPH Healthcare Services. This collaboration aims to provide affordable telemedicine services to approximately 100 Kinney Drug retail pharmacies in New York and Vermont and over two million Rx discount card members from ProAct, Inc. By leveraging Bonum Health's mobile B2C clinical technology, the partnership enhances access to virtual medical consultations, thereby addressing healthcare needs amid COVID-19. The initiative seeks to improve medication adherence and overall health outcomes for patients in the region.
Trxade Group (MEDS) announced its participation in the Diamond Equity Research Emerging Growth Invitational on December 1, 2020. CEO Suren Ajjarapu will lead a virtual presentation at 3:40 p.m. ET, followed by a Q&A session. This conference showcases emerging growth companies, and Trxade aims to enhance investor engagement and showcase its integrated drug procurement and healthcare services. A live audio webcast and an archived replay will be available post-event, facilitating broader accessibility.
Trxade Group (MEDS) announced participation in the Virtual Fall Investor Summit on November 17, 2020, at 2:30 p.m. Eastern Time. CEO Suren Ajjarapu will engage in one-on-one meetings and present about the company's integrated drug procurement and healthcare platform, which focuses on price transparency and accessibility. The event runs from November 16-18, 2020, and a live audio webcast will be available for public access through a specified link until November 16, 2021.
Trxade Group (NASDAQ: MEDS) reported a 174% revenue increase to $6.3 million in Q3 2020, driven by strong PPE sales amid the COVID-19 pandemic. Gross profit rose 47% to $1.9 million, but gross margin fell to 30.5%. Net income surged 402% to $0.14 million with adjusted EBITDA up 150%. The company expanded its platform by adding 144 new pharmacies, totaling around 11,800. Additionally, Trxade launched Bonum+, a B2B telehealth solution for corporate clients, enhancing its service offerings amidst ongoing healthcare challenges.
Trxade Group (MEDS) will announce its third-quarter financial results on October 26, 2020, after market close. A conference call is scheduled for the same day at 5:00 p.m. Eastern time to discuss the results, with a Q&A session following. Interested participants should dial in at least 10 minutes early. A playback will be available through November 26, 2020. Trxade Group focuses on improving the affordability and accessibility of healthcare through its integrated platforms.
Trxade Group (NASDAQ: MEDS) announced a partnership between its Bonum Health subsidiary and SingleCare to enhance telehealth solutions with prescription discounts. This initiative aims to support uninsured and underserved communities amid rising healthcare costs due to COVID-19. Bonum Health offers affordable virtual consultations by licensed medical professionals. The partnership is designed to help more consumers access low-cost medications and improve adherence to prescriptions, with SingleCare providing discounts of up to 80% on prescriptions.
Trxade Group (NASDAQ: MEDS) will participate in two upcoming investor conferences in September 2020. The first is the Colliers Institutional Investor Conference on September 10, followed by the H.C. Wainwright 22nd Annual Global Investment Conference from September 14-16. CEO Suren Ajjarapu will host a virtual presentation at the Wainwright event and engage in one-on-one meetings. Trxade Group aims to enhance healthcare access and affordability through its integrated drug procurement and delivery platform, operating across all 50 states.
Trxade Group, Inc. (NASDAQ: MEDS) has introduced the Bonum+ platform, a comprehensive Business-to-Business (B2B) solution combining telehealth services, a COVID-19 risk assessment tool, and PPE purchasing options through a secure mobile dashboard. This innovative platform facilitates daily health reporting for employees, enhancing monitoring capabilities for employers. It features an AI tool providing health recommendations and access to board-certified physicians. The initiative aims to bolster workplace safety amidst ongoing COVID-19 challenges and anticipates further service expansions, including digital health concierge services.
